• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neogenomics Inc (NQ: NEO )

    14.17 +0.36 (+2.61%)
    Streaming Delayed Price Updated: 12:45 PM EDT, Oct 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Neogenomics Inc

    < Previous 1 2 3 4 5 6 Next >
    Expert Ratings For NeoGenomics
    Via Benzinga
    Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
    Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio! 
    Via Benzinga
    Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024
    NEO stock results show that NeoGenomics beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    NeoGenomics Earnings Analysis: Q1 Recap
    Via Benzinga
    PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Where NeoGenomics Stands With Analysts
    Via Benzinga
    NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
    NEO stock results show that NeoGenomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    What 6 Analyst Ratings Have To Say About NeoGenomics
    Via Benzinga
    Earnings Scheduled For March 15, 2024
    Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million. 
    Via Benzinga
    Evaluating NeoGenomics: Insights From 4 Financial Analysts
    Via Benzinga
    Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
    Via Benzinga
    NeoGenomics Stock Surged But Technicals Point To A Pullback
    NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than... 
    Via Talk Markets
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... 
    Via Benzinga
    Recap: NeoGenomics Q4 Earnings
    Via Benzinga
    NeoGenomics's Earnings Outlook
    Via Benzinga
    Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
    NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an... 
    Via Benzinga
    Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
    The company must pay $57 million in damages, but that's far less than expected. 
    Via Investor's Business Daily
    Topics Intellectual Property
    Exposures Intellectual Property
    Earnings Scheduled For February 20, 2024
    Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
    Via Benzinga
    Bull of the Day - NeoGenomics
    But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context. 
    Via Talk Markets
    Topics Intellectual Property
    Exposures Intellectual Property
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
    Via Benzinga
    Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. 
    Via Benzinga
    US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
    Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from  
    Via Benzinga
    Stocks Edge Higher As End Of 2023 Approaches
    The SPX is less than 10 points away from record close territory, and with one day left, all three major indexes are heading toward sizable December wins. 
    Via Talk Markets
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.